Biogen, Elan post Tysabri-fueled sales hikes; KKR wins European nod for Capsugel deal;

@FiercePharma: Cal/OSHA fines Baxter for plant safety violations. News | Follow @FiercePharma

> Biogen Idec's second-quarter sales beat analyst expectations, fueled by fast growth in new prescriptions of its multiple sclerosis drug Tysabri. Story

> Private equity firm KKR won European approval for its $2.38 billion deal to buy Pfizer's Capsugel unit. Article

> Elan's Q2 profits grew $59.7 million, beating analyst estimates, on strong sales of Tysabri; the company raised its full-year profits target. Piece

> Gilead Sciences posted a rise in second-quarter profits to $746.2 million, fueled by street-beating sales of its leading HIV products. Article

> Takeda Pharmaceutical said it would borrow ¥600 billion ($7.66 billion) to finance its ¥1.1 trillion buyout of the Swiss drugmaker Nycomed. News

> Hospira posted a 10% hike in second-quarter sales to $1.06 billion, aided in part by strong U.S. revenues from its prostate cancer drug oncolytic docetaxel. Report

> New products helped boost Mylan's generic-drug sales in the U.S., but European sales suffered from pricing pressures. Report

> U.S antitrust regulators approved Perrigo's purchase of Paddock Labs, on the condition that it sell off 6 generic drugs and agree to provisions that would ensure competition in the market for testosterone gel products. Story

> Hexal, a unit of the Novartis generic operation Sandoz, said it withdrew from FDA an application to market its version of the Roche cancer drug Bondronat. More

> Shire said investment banker Susan Kilsby, most recently a senior advisor at Credit Suisse, has joined its board. Report

Biotech News

@FierceBiotech: GSK relying on Ph3 strategy in R&D comeback bid. Piece | Follow @FierceBiotech

@JohnCFierce: Worked with Cetero? FDA cites "corrupt" CRO for widespread falsification News | Follow @JohnCFierce

@RyanMFierce: If you were meeting with Biogen CEO George Scangos today, what would you ask him? Soliciting comments ahead of my trip to $BIIB in Weston. | Follow @RyanMFierce

@MaureenFierce: Ford, Toyota jump into medical device business with ECG-sensing cars. Story | Follow @MaureenFierce

> FDA cites "corrupt" CRO for widespread falsification. Report

> Cancer drug upstart adds $18M in venture cash to state grant. News

> Bayer partners on Trius' Ph3 antibiotic in $94M pact. More

> Amylin heading back to the FDA with Bydureon app. Article

> Survey: Clinical trial costs spike on bigger staffs, recruiting costs. Item

Drug Delivery News

> SPANosomes deliver siRNA more effectively. More

> Zcube, Caltech get together for nanotube-needle drug delivery. Article

> Nanowires are actually swimmers for drug delivery bots. Story

> E-cigarrettes blasted as dangerous drug delivery devices in NEJM. Article

Medical Devices News

> CareFusion to sell ResMed ventilators in U.S. Report

> Medtronic beats Boston Scientific in drug-eluting stent studies. More

> Sunshine Heart raises $5M, readies for C-pulse trials. Article

> IOM report on changes in medical devices approvals expected on Friday. News

> Toyota unveils steering-wheel ECG sensors. Story

> Report: In-home medical devices must be easier to use. Report

And Finally... Is it possible to predict whether someone is likely to survive or die suddenly from a heart attack? Report

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.